Recent Update in Pharmacological Agents for Optic Pathway Glioma.

Brain Tumor Res Treat · 2022 · PMC9098979 · PMID 35545829

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

Alternative therapies such as the thioguanine, procarbazine, lomustine, vincristine (TPCV) showed a nonsignificant trend toward improved event-free survival when compared with carboplatin/vincristine in patients with NF1 [ 15 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.